Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1993 Sep;69(815):679–695. doi: 10.1136/pgmj.69.815.679

Triglycerides and disease.

C A Seymour 1, C D Byrne 1
PMCID: PMC2399798  PMID: 8255832

Full text

PDF
679

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AHRENS E. H., Jr, INSULL W., Jr, BLOMSTRAND R., HIRSCH J., TSALTAS T. T., PETERSON M. L. The influence of dietary fats on serum-lipid levels in man. Lancet. 1957 May 11;272(6976):943–953. doi: 10.1016/s0140-6736(57)91280-1. [DOI] [PubMed] [Google Scholar]
  2. ANTONIS A., BERSOHN I. Serum-triglyceride levels in South African Europeans and Bantu and in ischaemic heart-disease. Lancet. 1960 May 7;1(7132):998–1002. doi: 10.1016/s0140-6736(60)90886-2. [DOI] [PubMed] [Google Scholar]
  3. Abbott R. D., Carroll R. J. Interpreting multiple logistic regression coefficients in prospective observational studies. Am J Epidemiol. 1984 May;119(5):830–836. doi: 10.1093/oxfordjournals.aje.a113803. [DOI] [PubMed] [Google Scholar]
  4. Abrams J. J., Ginsberg H., Grundy S. M. Metabolism of cholesterol and plasma triglycerides in nonketotic diabetes mellitus. Diabetes. 1982 Oct;31(10):903–910. doi: 10.2337/diab.31.10.903. [DOI] [PubMed] [Google Scholar]
  5. Adeli K., Sinkevitch C. Secretion of apolipoprotein B in serum-free cultures of human hepatoma cell line, HepG2. FEBS Lett. 1990 Apr 24;263(2):345–348. doi: 10.1016/0014-5793(90)81410-p. [DOI] [PubMed] [Google Scholar]
  6. Agardh C. D., Nilsson-Ehle P., Scherstén B. Improvement of the plasma lipoprotein pattern after institution of insulin treatment in diabetes mellitus. Diabetes Care. 1982 May-Jun;5(3):322–325. doi: 10.2337/diacare.5.3.322. [DOI] [PubMed] [Google Scholar]
  7. Al-Muhtaseb N., Hayat N., Al-Khafaji M. Lipoproteins and apolipoproteins in young male survivors of myocardial infarction. Atherosclerosis. 1989 Jun;77(2-3):131–138. doi: 10.1016/0021-9150(89)90074-9. [DOI] [PubMed] [Google Scholar]
  8. Alberti K. G., Gries F. A. Management of non-insulin-dependent diabetes mellitus in Europe: a concensus view. Diabet Med. 1988 Apr;5(3):275–281. doi: 10.1111/j.1464-5491.1988.tb00984.x. [DOI] [PubMed] [Google Scholar]
  9. Alcindor L. G., Infante R., Soler-Argilaga C., Polonovski J. Effect of a single insulin administration on the hepatic release of triglycerides into the plasma. Biochim Biophys Acta. 1973 Jun 21;306(3):347–352. doi: 10.1016/0005-2760(73)90173-2. [DOI] [PubMed] [Google Scholar]
  10. Anderson A. J., Barboriak J. J., Rimm A. A. Risk factors and angiographically determined coronary occlusion. Am J Epidemiol. 1978 Jan;107(1):8–14. doi: 10.1093/oxfordjournals.aje.a112511. [DOI] [PubMed] [Google Scholar]
  11. Annuzzi G., Rivellese A., Capaldo B., Di Marino L., Iovine C., Marotta G., Riccardi G. A controlled study on the effects of n-3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients. Atherosclerosis. 1991 Mar;87(1):65–73. doi: 10.1016/0021-9150(91)90233-s. [DOI] [PubMed] [Google Scholar]
  12. Arntzenius A. C., Kromhout D., Barth J. D., Reiber J. H., Bruschke A. V., Buis B., van Gent C. M., Kempen-Voogd N., Strikwerda S., van der Velde E. A. Diet, lipoproteins, and the progression of coronary atherosclerosis. The Leiden Intervention Trial. N Engl J Med. 1985 Mar 28;312(13):805–811. doi: 10.1056/NEJM198503283121301. [DOI] [PubMed] [Google Scholar]
  13. Assmann G., Brewer H. B., Jr Genetic (primary) forms of hypertriglyceridemia. Am J Cardiol. 1991 Jul 24;68(3):13A–16A. doi: 10.1016/0002-9149(91)90854-e. [DOI] [PubMed] [Google Scholar]
  14. Bamberger M. J., Lane M. D. Possible role of the Golgi apparatus in the assembly of very low density lipoprotein. Proc Natl Acad Sci U S A. 1990 Apr;87(7):2390–2394. doi: 10.1073/pnas.87.7.2390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Banerji M. A., Lebovitz H. E. Insulin-sensitive and insulin-resistant variants in NIDDM. Diabetes. 1989 Jun;38(6):784–792. doi: 10.2337/diab.38.6.784. [DOI] [PubMed] [Google Scholar]
  16. Bang H. O., Dyerberg J., Hjøorne N. The composition of food consumed by Greenland Eskimos. Acta Med Scand. 1976;200(1-2):69–73. doi: 10.1111/j.0954-6820.1976.tb08198.x. [DOI] [PubMed] [Google Scholar]
  17. Barbir M., Wile D., Trayner I., Aber V. R., Thompson G. R. High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease. Br Heart J. 1988 Nov;60(5):397–403. doi: 10.1136/hrt.60.5.397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Barboriak J. J., Rimm A. A., Anderson A. J., Tristani F. E., Walker J. A., Flemma R. J. Coronary artery occlusion and blood lipids. Am Heart J. 1974 Jun;87(6):716–721. doi: 10.1016/0002-8703(74)90416-5. [DOI] [PubMed] [Google Scholar]
  19. Bartlett S. M., Gibbons G. F. Short- and longer-term regulation of very-low-density lipoprotein secretion by insulin, dexamethasone and lipogenic substrates in cultured hepatocytes. A biphasic effect of insulin. Biochem J. 1988 Jan 1;249(1):37–43. doi: 10.1042/bj2490037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Berenson G. S., Turner M., O'Meallie L. P., Puyau F. A., Pargaonkar P. S., Srinivasan S., Hall R. J. A study of serum lipoproteins and angiographic evidence of coronary artery disease. South Med J. 1975 Dec;68(12):1513–1519. doi: 10.1097/00007611-197512000-00014. [DOI] [PubMed] [Google Scholar]
  21. Betteridge D. J. Lipids, diabetes, and vascular disease: the time to act. Diabet Med. 1989 Apr;6(3):195–218. doi: 10.1111/j.1464-5491.1989.tb01149.x. [DOI] [PubMed] [Google Scholar]
  22. Blankenhorn D. H., Nessim S. A., Johnson R. L., Sanmarco M. E., Azen S. P., Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA. 1987 Jun 19;257(23):3233–3240. [PubMed] [Google Scholar]
  23. Breier C., Patsch J. R., Mühlberger V., Drexel H., Knapp E., Braunsteiner H. Risk factors for coronary artery disease: a study comparing hypercholesterolaemia and hypertriglyceridaemia in angiographically characterized patients. Eur J Clin Invest. 1989 Oct;19(5):419–423. doi: 10.1111/j.1365-2362.1989.tb00253.x. [DOI] [PubMed] [Google Scholar]
  24. Brensike J. F., Levy R. I., Kelsey S. F., Passamani E. R., Richardson J. M., Loh I. K., Stone N. J., Aldrich R. F., Battaglini J. W., Moriarty D. J. Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study. Circulation. 1984 Feb;69(2):313–324. doi: 10.1161/01.cir.69.2.313. [DOI] [PubMed] [Google Scholar]
  25. Brindle N. P., Ontko J. A. Alpha-adrenergic suppression of very-low-density-lipoprotein triacylglycerol secretion by isolated rat hepatocytes. Biochem J. 1988 Mar 1;250(2):363–368. doi: 10.1042/bj2500363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Brown G., Albers J. J., Fisher L. D., Schaefer S. M., Lin J. T., Kaplan C., Zhao X. Q., Bisson B. D., Fitzpatrick V. F., Dodge H. T. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med. 1990 Nov 8;323(19):1289–1298. doi: 10.1056/NEJM199011083231901. [DOI] [PubMed] [Google Scholar]
  27. Brunner D., Altman S., Loebl K., Schwartz S., Levin S. Serum cholesterol and triglycerides in patients suffering from ischemic heart disease and in healthy subjects. Atherosclerosis. 1977 Oct;28(2):197–204. doi: 10.1016/0021-9150(77)90157-5. [DOI] [PubMed] [Google Scholar]
  28. Bu G., Williams S., Strickland D. K., Schwartz A. L. Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7427–7431. doi: 10.1073/pnas.89.16.7427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Byrne C. D., Brindle N. P., Wang T. W., Hales C. N. Interaction of non-esterified fatty acid and insulin in control of triacylglycerol secretion by Hep G2 cells. Biochem J. 1991 Nov 15;280(Pt 1):99–104. doi: 10.1042/bj2800099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Byrne C. D., Wang T. W., Hales C. N. Control of Hep G2-cell triacylglycerol and apolipoprotein B synthesis and secretion by polyunsaturated non-esterified fatty acids and insulin. Biochem J. 1992 Nov 15;288(Pt 1):101–107. doi: 10.1042/bj2880101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. CARLSON L. A., ORO L. The effect of nicotinic acid on the plasma free fatty acid; demonstration of a metabolic type of sympathicolysis. Acta Med Scand. 1962 Dec;172:641–645. doi: 10.1111/j.0954-6820.1962.tb07203.x. [DOI] [PubMed] [Google Scholar]
  32. CARLSON L. A. Serum lipids in men with myocardial infarction. Acta Med Scand. 1960 Aug 31;167:399–413. doi: 10.1111/j.0954-6820.1960.tb03562.x. [DOI] [PubMed] [Google Scholar]
  33. Campos H., Genest J. J., Jr, Blijlevens E., McNamara J. R., Jenner J. L., Ordovas J. M., Wilson P. W., Schaefer E. J. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb. 1992 Feb;12(2):187–195. doi: 10.1161/01.atv.12.2.187. [DOI] [PubMed] [Google Scholar]
  34. Camps L., Reina M., Llobera M., Bengtsson-Olivecrona G., Olivecrona T., Vilaró S. Lipoprotein lipase in lungs, spleen, and liver: synthesis and distribution. J Lipid Res. 1991 Dec;32(12):1877–1888. [PubMed] [Google Scholar]
  35. Carlson L. A., Hamsten A., Asplund A. Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid. J Intern Med. 1989 Oct;226(4):271–276. doi: 10.1111/j.1365-2796.1989.tb01393.x. [DOI] [PubMed] [Google Scholar]
  36. Carlson L. A., Orö L., Ostman J. Effect of a single dose of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia. Acta Med Scand. 1968 May;183(5):457–465. doi: 10.1111/j.0954-6820.1968.tb10508.x. [DOI] [PubMed] [Google Scholar]
  37. Carlson L. A., Rosenhamer G. Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid. Acta Med Scand. 1988;223(5):405–418. doi: 10.1111/j.0954-6820.1988.tb15891.x. [DOI] [PubMed] [Google Scholar]
  38. Carvalho de Sousa J., Bruckert E., Giral P., Soria C., Chapman J., Truffert J., Dairou F., De Gennes J. L., Caen J. P. Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity. Haemostasis. 1989;19(3):125–130. doi: 10.1159/000215904. [DOI] [PubMed] [Google Scholar]
  39. Cascales C., Mangiapane E. H., Brindley D. N. Oleic acid promotes the activation and translocation of phosphatidate phosphohydrolase from the cytosol to particulate fractions of isolated rat hepatocytes. Biochem J. 1984 May 1;219(3):911–916. doi: 10.1042/bj2190911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Castelli W. P., Doyle J. T., Gordon T., Hames C. G., Hjortland M. C., Hulley S. B., Kagan A., Zukel W. J. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation. 1977 May;55(5):767–772. doi: 10.1161/01.cir.55.5.767. [DOI] [PubMed] [Google Scholar]
  41. Castro G. R., Fielding C. J. Effects of postprandial lipemia on plasma cholesterol metabolism. J Clin Invest. 1985 Mar;75(3):874–882. doi: 10.1172/JCI111786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Chang N. W., Huang P. C. Effects of dietary monounsaturated fatty acids on plasma lipids in humans. J Lipid Res. 1990 Dec;31(12):2141–2147. [PubMed] [Google Scholar]
  43. Chen S. H., Habib G., Yang C. Y., Gu Z. W., Lee B. R., Weng S. A., Silberman S. R., Cai S. J., Deslypere J. P., Rosseneu M. Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science. 1987 Oct 16;238(4825):363–366. doi: 10.1126/science.3659919. [DOI] [PubMed] [Google Scholar]
  44. Cohn P. F., Gabbay S. I., Weglicki W. B. Serum lipid levels in angiographically defined coronary artery disease. Ann Intern Med. 1976 Mar;84(3):241–245. doi: 10.7326/0003-4819-84-3-241. [DOI] [PubMed] [Google Scholar]
  45. Cramér K., Paulin S., Werkö L. Coronary angiographic findings in correlation with age, body weight, blood pressure, serum lipids, and smoking habits. Circulation. 1966 Jun;33(6):888–900. doi: 10.1161/01.cir.33.6.888. [DOI] [PubMed] [Google Scholar]
  46. Dalaker K., Hjermann I., Prydz H. A novel form of factor VII in plasma from men at risk for cardiovascular disease. Br J Haematol. 1985 Oct;61(2):315–322. doi: 10.1111/j.1365-2141.1985.tb02831.x. [DOI] [PubMed] [Google Scholar]
  47. Dalaker K., Skartlien A. H., Prydz H. A new form of coagulation factor VII in plasma. Scand J Haematol. 1986 May;36(5):430–438. doi: 10.1111/j.1600-0609.1986.tb02277.x. [DOI] [PubMed] [Google Scholar]
  48. Dashti N., Smith E. A., Alaupovic P. Increased production of apolipoprotein B and its lipoproteins by oleic acid in Caco-2 cells. J Lipid Res. 1990 Jan;31(1):113–123. [PubMed] [Google Scholar]
  49. Dashti N., Williams D. L., Alaupovic P. Effects of oleate and insulin on the production rates and cellular mRNA concentrations of apolipoproteins in HepG2 cells. J Lipid Res. 1989 Sep;30(9):1365–1373. [PubMed] [Google Scholar]
  50. Dashti N., Wolfbauer G. Secretion of lipids, apolipoproteins, and lipoproteins by human hepatoma cell line, HepG2: effects of oleic acid and insulin. J Lipid Res. 1987 Apr;28(4):423–436. [PubMed] [Google Scholar]
  51. De Tomas M. E., Mercuri O. The in vivo incorporation of labeled linoleic acid, -linolenic acid and arachidonic acid into rat liver lipids. Lipids. 1971 Nov;6(11):787–790. doi: 10.1007/BF02531206. [DOI] [PubMed] [Google Scholar]
  52. Dean J. D., Jones C. J., Hutchison S. J., Peters J. R., Henderson A. H. Hyperinsulinaemia and microvascular angina ("syndrome X") Lancet. 1991 Feb 23;337(8739):456–457. [PubMed] [Google Scholar]
  53. Demant T., Carlson L. A., Holmquist L., Karpe F., Nilsson-Ehle P., Packard C. J., Shepherd J. Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein. J Lipid Res. 1988 Dec;29(12):1603–1611. [PubMed] [Google Scholar]
  54. Dich J., Bro B., Grunnet N., Jensen F., Kondrup J. Accumulation of triacylglycerol in cultured rat hepatocytes is increased by ethanol and by insulin and dexamethasone. Biochem J. 1983 Jun 15;212(3):617–623. doi: 10.1042/bj2120617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Dich J., Bro B., Grunnet N., Jensen F., Kondrup J. Accumulation of triacylglycerol in cultured rat hepatocytes is increased by ethanol and by insulin and dexamethasone. Biochem J. 1983 Jun 15;212(3):617–623. doi: 10.1042/bj2120617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Dixon J. L., Furukawa S., Ginsberg H. N. Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B. J Biol Chem. 1991 Mar 15;266(8):5080–5086. [PubMed] [Google Scholar]
  57. Duerden J. M., Bartlett S. M., Gibbons G. F. Long-term maintenance of high rates of very-low-density-lipoprotein secretion in hepatocyte cultures. A model for studying the direct effects of insulin and insulin deficiency in vitro. Biochem J. 1989 Nov 1;263(3):937–943. doi: 10.1042/bj2630937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Duerden J. M., Bartlett S. M., Gibbons G. F. Regulation of very-low-density-lipoprotein lipid secretion in hepatocyte cultures derived from diabetic animals. Biochem J. 1989 Aug 15;262(1):313–319. doi: 10.1042/bj2620313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Duerden J. M., Gibbons G. F. Secretion and storage of newly synthesized hepatic triacylglycerol fatty acids in vivo in different nutritional states and in diabetes. Biochem J. 1988 Nov 1;255(3):929–935. doi: 10.1042/bj2550929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Dullaart R. P., Dikkeschei L. D., Doorenbos H. Alterations in serum lipids and apolipoproteins in male type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia. 1989 Sep;32(9):685–689. doi: 10.1007/BF00274257. [DOI] [PubMed] [Google Scholar]
  61. Dunn F. L. Hyperlipidemia in diabetes mellitus. Diabetes Metab Rev. 1990 Feb;6(1):47–61. doi: 10.1002/dmr.5610060103. [DOI] [PubMed] [Google Scholar]
  62. Durrington P. N., Newton R. S., Weinstein D. B., Steinberg D. Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes. J Clin Invest. 1982 Jul;70(1):63–73. doi: 10.1172/JCI110604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Dyerberg J., Bang H. O., Hjorne N. Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr. 1975 Sep;28(9):958–966. doi: 10.1093/ajcn/28.9.958. [DOI] [PubMed] [Google Scholar]
  64. Fager G., Wiklund O., Olofsson S. O., Wilhelmsen L., Bondjers G. Multivariate analyses of serum apolipoproteins and risk factors in relation to acute myocardial infarction. Arteriosclerosis. 1981 Jul-Aug;1(4):273–279. doi: 10.1161/01.atv.1.4.273. [DOI] [PubMed] [Google Scholar]
  65. Fasching P., Ratheiser K., Waldhäusl W., Rohac M., Osterrode W., Nowotny P., Vierhapper H. Metabolic effects of fish-oil supplementation in patients with impaired glucose tolerance. Diabetes. 1991 May;40(5):583–589. doi: 10.2337/diab.40.5.583. [DOI] [PubMed] [Google Scholar]
  66. Ferrannini E., Haffner S. M., Mitchell B. D., Stern M. P. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 1991 Jun;34(6):416–422. doi: 10.1007/BF00403180. [DOI] [PubMed] [Google Scholar]
  67. Ferrari P., Weidmann P., Shaw S., Giachino D., Riesen W., Allemann Y., Heynen G. Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. Am J Med. 1991 Dec;91(6):589–596. doi: 10.1016/0002-9343(91)90211-f. [DOI] [PubMed] [Google Scholar]
  68. Fontbonne A., Charles M. A., Thibult N., Richard J. L., Claude J. R., Warnet J. M., Rosselin G. E., Eschwège E. Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia. 1991 May;34(5):356–361. doi: 10.1007/BF00405009. [DOI] [PubMed] [Google Scholar]
  69. Freedman D. S., Gruchow H. W., Anderson A. J., Rimm A. A., Barboriak J. J. Relation of triglyceride levels to coronary artery disease: the Milwaukee Cardiovascular Data Registry. Am J Epidemiol. 1988 Jun;127(6):1118–1130. doi: 10.1093/oxfordjournals.aje.a114906. [DOI] [PubMed] [Google Scholar]
  70. Gianturco S. H., Bradley W. A., Gotto A. M., Jr, Morrisett J. D., Peavy D. L. Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages. J Clin Invest. 1982 Jul;70(1):168–178. doi: 10.1172/JCI110590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Gibbons G. F. Assembly and secretion of hepatic very-low-density lipoprotein. Biochem J. 1990 May 15;268(1):1–13. doi: 10.1042/bj2680001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Gibbons G. F., Burnham F. J. Effect of nutritional state on the utilization of fatty acids for hepatitic triacylglycerol synthesis and secretion as very-low-density lipoprotein. Biochem J. 1991 Apr 1;275(Pt 1):87–92. doi: 10.1042/bj2750087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Ginsberg H. N. Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis. Diabetes Care. 1991 Sep;14(9):839–855. doi: 10.2337/diacare.14.9.839. [DOI] [PubMed] [Google Scholar]
  74. Golay A., Chen Y. D., Reaven G. M. Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrate and free fatty acid metabolism in obese individuals. J Clin Endocrinol Metab. 1986 Jun;62(6):1081–1088. doi: 10.1210/jcem-62-6-1081. [DOI] [PubMed] [Google Scholar]
  75. Goldstein J. L., Hazzard W. R., Schrott H. G., Bierman E. L., Motulsky A. G. Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. J Clin Invest. 1973 Jul;52(7):1533–1543. doi: 10.1172/JCI107331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Goldstein J. L., Ho Y. K., Brown M. S., Innerarity T. L., Mahley R. W. Cholesteryl ester accumulation in macrophages resulting from receptor-mediated uptake and degradation of hypercholesterolemic canine beta-very low density lipoproteins. J Biol Chem. 1980 Mar 10;255(5):1839–1848. [PubMed] [Google Scholar]
  77. Gordon T., Castelli W. P., Hjortland M. C., Kannel W. B., Dawber T. R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977 May;62(5):707–714. doi: 10.1016/0002-9343(77)90874-9. [DOI] [PubMed] [Google Scholar]
  78. Gotto A. M., Gorry G. A., Thompson J. R., Cole J. S., Trost R., Yeshurun D., DeBakey M. E. Relationship between plasma lipid concentrations and coronary artery disease in 496 patients. Circulation. 1977 Nov;56(5):875–883. doi: 10.1161/01.cir.56.5.875. [DOI] [PubMed] [Google Scholar]
  79. Groop L. C., Saloranta C., Shank M., Bonadonna R. C., Ferrannini E., DeFronzo R. A. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1991 Jan;72(1):96–107. doi: 10.1210/jcem-72-1-96. [DOI] [PubMed] [Google Scholar]
  80. Grundy S. M. Monounsaturated fatty acids and cholesterol metabolism: implications for dietary recommendations. J Nutr. 1989 Apr;119(4):529–533. doi: 10.1093/jn/119.4.529. [DOI] [PubMed] [Google Scholar]
  81. Gustafson A., Elmfeldt D., Wilhelmsen L., Tibblin G. Serum lipids and lipoproteins in men after myocardial infarction compared with representative population sample. Circulation. 1972 Oct;46(4):709–716. doi: 10.1161/01.cir.46.4.709. [DOI] [PubMed] [Google Scholar]
  82. Haagsman H. P., Van Golde L. M. Synthesis and secretion of very low density lipoproteins by isolated rat hepatocytes in suspension: role of diacylglycerol acyltransferase. Arch Biochem Biophys. 1981 May;208(2):395–402. doi: 10.1016/0003-9861(81)90524-5. [DOI] [PubMed] [Google Scholar]
  83. Hamsten A., Walldius G., Dahlén G., Johansson B., De Faire U. Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction. Atherosclerosis. 1986 Feb;59(2):223–235. doi: 10.1016/0021-9150(86)90051-1. [DOI] [PubMed] [Google Scholar]
  84. Harris W. S. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res. 1989 Jun;30(6):785–807. [PubMed] [Google Scholar]
  85. Hegsted D. M., McGandy R. B., Myers M. L., Stare F. J. Quantitative effects of dietary fat on serum cholesterol in man. Am J Clin Nutr. 1965 Nov;17(5):281–295. doi: 10.1093/ajcn/17.5.281. [DOI] [PubMed] [Google Scholar]
  86. Higgins J. A. Evidence that during very low density lipoprotein assembly in rat hepatocytes most of the triacylglycerol and phospholipid are packaged with apolipoprotein B in the Golgi complex. FEBS Lett. 1988 May 23;232(2):405–408. doi: 10.1016/0014-5793(88)80780-4. [DOI] [PubMed] [Google Scholar]
  87. Hiramatsu K., Arimori S. Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes. Diabetes. 1988 Jun;37(6):832–837. doi: 10.2337/diab.37.6.832. [DOI] [PubMed] [Google Scholar]
  88. Hjermann I., Holme I., Leren P. Oslo Study Diet and Antismoking Trial. Results after 102 months. Am J Med. 1986 Feb 14;80(2A):7–11. doi: 10.1016/0002-9343(86)90154-3. [DOI] [PubMed] [Google Scholar]
  89. Holmes D. R., Jr, Elveback L. R., Frye R. L., Kottke B. A., Ellefson R. D. Association of risk factor variables and coronary artery disease documented with angiography. Circulation. 1981 Feb;63(2):293–299. doi: 10.1161/01.cir.63.2.293. [DOI] [PubMed] [Google Scholar]
  90. Homan R., Grossman J. E., Pownall H. J. Differential effects of eicosapentaenoic acid and oleic acid on lipid synthesis and secretion by HepG2 cells. J Lipid Res. 1991 Feb;32(2):231–241. [PubMed] [Google Scholar]
  91. Howard B. V. Lipoprotein metabolism in diabetes mellitus. J Lipid Res. 1987 Jun;28(6):613–628. [PubMed] [Google Scholar]
  92. Hughes T. A., Clements R. S., Fairclough P. K., Bell D. S., Segrest J. P. Effect of insulin therapy on lipoproteins in non-insulin dependent diabetes mellitus (NIDDM). Atherosclerosis. 1987 Oct;67(2-3):105–114. doi: 10.1016/0021-9150(87)90271-1. [DOI] [PubMed] [Google Scholar]
  93. Janka H. U., Standl E. Hyperinsulinaemia as a possible risk factor of macrovascular disease in diabetes mellitus. An overview. Diabete Metab. 1987 Jul;13(3 Pt 2):279–283. [PubMed] [Google Scholar]
  94. Jarrett R. J., Shipley M. J. Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease--putative association via common antecedents; further evidence from the Whitehall Study. Diabetologia. 1988 Oct;31(10):737–740. doi: 10.1007/BF00274775. [DOI] [PubMed] [Google Scholar]
  95. Jenkins A. J., Steele J. S., Janus E. D., Best J. D. Increased plasma apolipoprotein(a) levels in IDDM patients with microalbuminuria. Diabetes. 1991 Jun;40(6):787–790. doi: 10.2337/diab.40.6.787. [DOI] [PubMed] [Google Scholar]
  96. Jensen T., Stender S., Deckert T. Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion. Diabetologia. 1988 Mar;31(3):142–145. doi: 10.1007/BF00276846. [DOI] [PubMed] [Google Scholar]
  97. Jones S. L., Close C. F., Mattock M. B., Jarrett R. J., Keen H., Viberti G. C. Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. BMJ. 1989 Feb 25;298(6672):487–490. doi: 10.1136/bmj.298.6672.487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Juhan-Vague I., Vague P., Alessi M. C., Badier C., Valadier J., Aillaud M. F., Atlan C. Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1. Diabete Metab. 1987 Jul;13(3 Pt 2):331–336. [PubMed] [Google Scholar]
  99. Kannel W. B., McGee D. L. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979 May 11;241(19):2035–2038. doi: 10.1001/jama.241.19.2035. [DOI] [PubMed] [Google Scholar]
  100. Kapelrud H., Bangstad H. J., Dahl-Jørgensen K., Berg K., Hanssen K. F. Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria. BMJ. 1991 Sep 21;303(6804):675–678. doi: 10.1136/bmj.303.6804.675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Kaukola S., Manninen V., Halonen P. I. Serum lipids with special reference to HDL cholesterol and triglycerides in young male survivors of acute myocardial infarction. Acta Med Scand. 1980;208(1-2):41–43. doi: 10.1111/j.0954-6820.1980.tb01147.x. [DOI] [PubMed] [Google Scholar]
  102. Kim D. N., Schmee J., Lee C. S., Eastman A., Ross J. S., Thomas W. A. Comparison of effects of fish oil and corn oil supplements on hyperlipidemic diet induced atherogenesis in swine. Atherosclerosis. 1991 Aug;89(2-3):191–201. doi: 10.1016/0021-9150(91)90060-g. [DOI] [PubMed] [Google Scholar]
  103. Kissebah A. H., Alfarsi S., Adams P. W. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia. Metabolism. 1981 Sep;30(9):856–868. doi: 10.1016/0026-0495(81)90064-0. [DOI] [PubMed] [Google Scholar]
  104. Kissebah A. H., Alfarsi S., Evans D. J., Adams P. W. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus. Diabetes. 1982 Mar;31(3):217–225. doi: 10.2337/diab.31.3.217. [DOI] [PubMed] [Google Scholar]
  105. Kissebah A. H., Peiris A. N. Biology of regional body fat distribution: relationship to non-insulin-dependent diabetes mellitus. Diabetes Metab Rev. 1989 Mar;5(2):83–109. doi: 10.1002/dmr.5610050202. [DOI] [PubMed] [Google Scholar]
  106. Kobayashi M., Shigeta Y., Hirata Y., Omori Y., Sakamoto N., Nambu S., Baba S. Improvement of glucose tolerance in NIDDM by clofibrate. Randomized double-blind study. Diabetes Care. 1988 Jun;11(6):495–499. doi: 10.2337/diacare.11.6.495. [DOI] [PubMed] [Google Scholar]
  107. Kobbah M., Vessby B., Tuvemo T. Serum lipids and apolipoproteins in children with type 1 (insulin-dependent) diabetes during the first two years of the disease. Diabetologia. 1988 Apr;31(4):195–200. doi: 10.1007/BF00290584. [DOI] [PubMed] [Google Scholar]
  108. Kostner G. M., Karádi I. Lipoprotein alterations in diabetes mellitus. Diabetologia. 1988 Oct;31(10):717–722. doi: 10.1007/BF00274772. [DOI] [PubMed] [Google Scholar]
  109. Laakso M., Pyörälä K., Voutilainen E., Marniemi J. Plasma insulin and serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetic and non-diabetic subjects. Am J Epidemiol. 1987 Apr;125(4):611–621. doi: 10.1093/oxfordjournals.aje.a114574. [DOI] [PubMed] [Google Scholar]
  110. Lang C. A., Davis R. A. Fish oil fatty acids impair VLDL assembly and/or secretion by cultured rat hepatocytes. J Lipid Res. 1990 Nov;31(11):2079–2086. [PubMed] [Google Scholar]
  111. Lewis B., Chait A., Oakley C. M., Wootton I. D., Krikler D. M., Onitiri A., Sigurdsson G., February A. Serum lipoprotein abnormalities in patients with ischaemic heart disease: comparisons with a control population. Br Med J. 1974 Aug 24;3(5929):489–493. doi: 10.1136/bmj.3.5929.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Lillioja S., Mott D. M., Howard B. V., Bennett P. H., Yki-Järvinen H., Freymond D., Nyomba B. L., Zurlo F., Swinburn B., Bogardus C. Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med. 1988 May 12;318(19):1217–1225. doi: 10.1056/NEJM198805123181901. [DOI] [PubMed] [Google Scholar]
  113. Liu G., Coulston A., Chen Y. D., Reaven G. M. Does day-long absolute hypoinsulinemia characterize the patient with non-insulin-dependent diabetes mellitus? Metabolism. 1983 Aug;32(8):754–756. doi: 10.1016/0026-0495(83)90104-x. [DOI] [PubMed] [Google Scholar]
  114. Mahley R. W., Innerarity T. L., Brown M. S., Ho Y. K., Goldstein J. L. Cholesteryl ester synthesis in macrophages: stimulation by beta-very low density lipoproteins from cholesterol-fed animals of several species. J Lipid Res. 1980 Nov;21(8):970–980. [PubMed] [Google Scholar]
  115. Malasanos T. H., Stacpoole P. W. Biological effects of omega-3 fatty acids in diabetes mellitus. Diabetes Care. 1991 Dec;14(12):1160–1179. doi: 10.2337/diacare.14.12.1160. [DOI] [PubMed] [Google Scholar]
  116. Mancini M., Steiner G., Betteridge D. J., Pometta D. Acquired (secondary) forms of hypertriglyceridemia. Am J Cardiol. 1991 Jul 24;68(3):17A–21A. doi: 10.1016/0002-9149(91)90855-f. [DOI] [PubMed] [Google Scholar]
  117. Mangiapane E. H., Brindley D. N. Effects of dexamethasone and insulin on the synthesis of triacylglycerols and phosphatidylcholine and the secretion of very-low-density lipoproteins and lysophosphatidylcholine by monolayer cultures of rat hepatocytes. Biochem J. 1986 Jan 1;233(1):151–160. doi: 10.1042/bj2330151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Manninen V., Elo M. O., Frick M. H., Haapa K., Heinonen O. P., Heinsalmi P., Helo P., Huttunen J. K., Kaitaniemi P., Koskinen P. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA. 1988 Aug 5;260(5):641–651. [PubMed] [Google Scholar]
  119. Martin-Sanz P., Vance J. E., Brindley D. N. Stimulation of apolipoprotein secretion in very-low-density and high-density lipoproteins from cultured rat hepatocytes by dexamethasone. Biochem J. 1990 Nov 1;271(3):575–583. doi: 10.1042/bj2710575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. McKane W. R., Stevens A. B., Woods R., Andrews W. J., Henry R. W., Bell P. M. The assessment of hepatic and peripheral insulin sensitivity in hypertriglyceridemia. Metabolism. 1990 Dec;39(12):1240–1245. doi: 10.1016/0026-0495(90)90177-e. [DOI] [PubMed] [Google Scholar]
  121. Meade T. W., Mellows S., Brozovic M., Miller G. J., Chakrabarti R. R., North W. R., Haines A. P., Stirling Y., Imeson J. D., Thompson S. G. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986 Sep 6;2(8506):533–537. doi: 10.1016/s0140-6736(86)90111-x. [DOI] [PubMed] [Google Scholar]
  122. Meade T. W., North W. R., Chakrabarti R., Stirling Y., Haines A. P., Thompson S. G., Brozovié M. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet. 1980 May 17;1(8177):1050–1054. doi: 10.1016/s0140-6736(80)91498-1. [DOI] [PubMed] [Google Scholar]
  123. Miller G. J., Martin J. C., Webster J., Wilkes H., Miller N. E., Wilkinson W. H., Meade T. W. Association between dietary fat intake and plasma factor VII coagulant activity--a predictor of cardiovascular mortality. Atherosclerosis. 1986 Jun;60(3):269–277. doi: 10.1016/0021-9150(86)90174-7. [DOI] [PubMed] [Google Scholar]
  124. Miller N. E., Hammett F., Saltissi S., Rao S., van Zeller H., Coltart J., Lewis B. Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins. Br Med J (Clin Res Ed) 1981 May 30;282(6278):1741–1744. doi: 10.1136/bmj.282.6278.1741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Mitropoulos K. A., Esnouf M. P., Meade T. W. Increased factor VII coagulant activity in the rabbit following diet-induced hypercholesterolaemia. Evidence for increased conversion of VII to alpha VIIa and higher flux within the coagulation pathway. Atherosclerosis. 1987 Jan;63(1):43–52. doi: 10.1016/0021-9150(87)90080-3. [DOI] [PubMed] [Google Scholar]
  126. Murthy S., Albright E., Mathur S. N., Field F. J. Effect of eicosapentaenoic acid on triacylglycerol transport in CaCo-2 cells. Biochim Biophys Acta. 1990 Jul 16;1045(2):147–155. doi: 10.1016/0005-2760(90)90144-m. [DOI] [PubMed] [Google Scholar]
  127. Nagi D. K., Hendra T. J., Ryle A. J., Cooper T. M., Temple R. C., Clark P. M., Schneider A. E., Hales C. N., Yudkin J. S. The relationships of concentrations of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects. Diabetologia. 1990 Sep;33(9):532–537. doi: 10.1007/BF00404140. [DOI] [PubMed] [Google Scholar]
  128. Nestel P. J., Billington T., Bazelmans J. Metabolism of human plasma triacylglycerol-rich lipoproteins in rodent macrophages: capacity for interaction at beta-VLDL receptor. Biochim Biophys Acta. 1985 Dec 4;837(3):314–324. doi: 10.1016/0005-2760(85)90055-4. [DOI] [PubMed] [Google Scholar]
  129. Nestel P. J., Connor W. E., Reardon M. F., Connor S., Wong S., Boston R. Suppression by diets rich in fish oil of very low density lipoprotein production in man. J Clin Invest. 1984 Jul;74(1):82–89. doi: 10.1172/JCI111422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Newnham H. H., Hopkins G. J., Devlin S., Barter P. J. Lipoprotein lipase prevents the hepatic lipase-induced reduction in particle size of high density lipoproteins during incubation of human plasma. Atherosclerosis. 1990 Jun;82(3):167–176. doi: 10.1016/0021-9150(90)90037-j. [DOI] [PubMed] [Google Scholar]
  131. Nossen J. O., Rustan A. C., Barnard T., Drevon C. A. Inhibition by chloroquine of the secretion of very low density lipoproteins by cultured rat hepatocytes. Biochim Biophys Acta. 1984 Feb 17;803(1-2):11–20. doi: 10.1016/0167-4889(84)90049-1. [DOI] [PubMed] [Google Scholar]
  132. Nossen J. O., Rustan A. C., Drevon C. A. Calcium-antagonists inhibit secretion of very-low-density lipoprotein from cultured rat hepatocytes. Biochem J. 1987 Oct 15;247(2):433–439. doi: 10.1042/bj2470433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Nossen J. O., Rustan A. C., Gloppestad S. H., Målbakken S., Drevon C. A. Eicosapentaenoic acid inhibits synthesis and secretion of triacylglycerols by cultured rat hepatocytes. Biochim Biophys Acta. 1986 Oct 24;879(1):56–65. doi: 10.1016/0005-2760(86)90266-3. [DOI] [PubMed] [Google Scholar]
  134. Olefsky J. M., Farquhar J. W., Reaven G. M. Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med. 1974 Oct;57(4):551–560. doi: 10.1016/0002-9343(74)90006-0. [DOI] [PubMed] [Google Scholar]
  135. Orchard T. J., Becker D. J., Bates M., Kuller L. H., Drash A. L. Plasma insulin and lipoprotein concentrations: an atherogenic association? Am J Epidemiol. 1983 Sep;118(3):326–337. doi: 10.1093/oxfordjournals.aje.a113639. [DOI] [PubMed] [Google Scholar]
  136. Orth K., Madison E. L., Gething M. J., Sambrook J. F., Herz J. Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1 are internalized by means of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7422–7426. doi: 10.1073/pnas.89.16.7422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Ostlund R. E., Jr, Staten M., Kohrt W. M., Schultz J., Malley M. The ratio of waist-to-hip circumference, plasma insulin level, and glucose intolerance as independent predictors of the HDL2 cholesterol level in older adults. N Engl J Med. 1990 Jan 25;322(4):229–234. doi: 10.1056/NEJM199001253220404. [DOI] [PubMed] [Google Scholar]
  138. Otto D. A., Tsai C. E., Baltzell J. K., Wooten J. T. Apparent inhibition of hepatic triacylglycerol secretion, independent of synthesis, in high-fat fish oil-fed rats: role for insulin. Biochim Biophys Acta. 1991 Feb 26;1082(1):37–48. doi: 10.1016/0005-2760(91)90297-u. [DOI] [PubMed] [Google Scholar]
  139. PETERS N., HALES C. N. PLASMA-INSULIN CONCENTRATIONS AFTER MYOCARDIAL INFRACTION. Lancet. 1965 May 29;1(7396):1144–1145. doi: 10.1016/s0140-6736(65)91962-8. [DOI] [PubMed] [Google Scholar]
  140. Park K. S., Rhee B. D., Lee K. U., Kim S. Y., Lee H. K., Koh C. S., Min H. K. Intra-abdominal fat is associated with decreased insulin sensitivity in healthy young men. Metabolism. 1991 Jun;40(6):600–603. doi: 10.1016/0026-0495(91)90050-7. [DOI] [PubMed] [Google Scholar]
  141. Parks J. S., Bullock B. C. Effect of fish oil versus lard diets on the chemical and physical properties of low density lipoproteins of nonhuman primates. J Lipid Res. 1987 Feb;28(2):173–182. [PubMed] [Google Scholar]
  142. Parthasarathy S., Quinn M. T., Schwenke D. C., Carew T. E., Steinberg D. Oxidative modification of beta-very low density lipoprotein. Potential role in monocyte recruitment and foam cell formation. Arteriosclerosis. 1989 May-Jun;9(3):398–404. doi: 10.1161/01.atv.9.3.398. [DOI] [PubMed] [Google Scholar]
  143. Patsch J. R., Karlin J. B., Scott L. W., Smith L. C., Gotto A. M., Jr Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. Proc Natl Acad Sci U S A. 1983 Mar;80(5):1449–1453. doi: 10.1073/pnas.80.5.1449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Patsch W., Franz S., Schonfeld G. Role of insulin in lipoprotein secretion by cultured rat hepatocytes. J Clin Invest. 1983 May;71(5):1161–1174. doi: 10.1172/JCI110865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Patsch W., Gotto A. M., Jr, Patsch J. R. Effects of insulin on lipoprotein secretion in rat hepatocyte cultures. The role of the insulin receptor. J Biol Chem. 1986 Jul 25;261(21):9603–9606. [PubMed] [Google Scholar]
  146. Patterson D., Slack J. Lipid abnormalities in male and female survivors of myocardial infarction and their first-degree relatives. Lancet. 1972 Feb 19;1(7747):393–399. doi: 10.1016/s0140-6736(72)90853-7. [DOI] [PubMed] [Google Scholar]
  147. Pittner R. A., Fears R., Brindley D. N. Effects of cyclic AMP, glucocorticoids and insulin on the activities of phosphatidate phosphohydrolase, tyrosine aminotransferase and glycerol kinase in isolated rat hepatocytes in relation to the control of triacylglycerol synthesis and gluconeogenesis. Biochem J. 1985 Jan 15;225(2):455–462. doi: 10.1042/bj2250455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Pullinger C. R., Gibbons G. F. The relationship between the rate of hepatic sterol synthesis and the incorporation of [3H]water. J Lipid Res. 1983 Oct;24(10):1321–1328. [PubMed] [Google Scholar]
  149. Pullinger C. R., North J. D., Teng B. B., Rifici V. A., Ronhild de Brito A. E., Scott J. The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J Lipid Res. 1989 Jul;30(7):1065–1077. [PubMed] [Google Scholar]
  150. Pyörälä K., Uusitupa M., Laakso M., Siitonen O., Niskanen L., Rönnemaa T. Macrovascular complications in relation to hyperinsulinaemia in non-insulin-dependent diabetes mellitus. Diabete Metab. 1987 Jul;13(3 Pt 2):345–349. [PubMed] [Google Scholar]
  151. Raison J., Bonithon-Kopp C., Egloff M., Ducimetiere P., Guy-Grand B. Hormonal influences on the relationships between body fatness, body fat distribution, lipids, lipoproteins, glucose and blood pressure in French working women. Atherosclerosis. 1990 Dec;85(2-3):185–192. doi: 10.1016/0021-9150(90)90110-5. [DOI] [PubMed] [Google Scholar]
  152. Razay G., Heaton K. W., Bolton C. H., Hughes A. O. Alcohol consumption and its relation to cardiovascular risk factors in British women. BMJ. 1992 Jan 11;304(6819):80–83. doi: 10.1136/bmj.304.6819.80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Reardon M. F., Nestel P. J., Craig I. H., Harper R. W. Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation. 1985 May;71(5):881–888. doi: 10.1161/01.cir.71.5.881. [DOI] [PubMed] [Google Scholar]
  154. Reaven G. M., Hollenbeck C. B., Chen Y. D. Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia. 1989 Jan;32(1):52–55. doi: 10.1007/BF00265404. [DOI] [PubMed] [Google Scholar]
  155. Rustan A. C., Nossen J. O., Christiansen E. N., Drevon C. A. Eicosapentaenoic acid reduces hepatic synthesis and secretion of triacylglycerol by decreasing the activity of acyl-coenzyme A:1,2-diacylglycerol acyltransferase. J Lipid Res. 1988 Nov;29(11):1417–1426. [PubMed] [Google Scholar]
  156. Salel A. F., Riggs K., Mason D. T., Amsterdam E. A., Zelis R. The importance of type IV hyperlipoproteinemia as a predisposing factor in coronary artery disease. Am J Med. 1974 Dec;57(6):897–903. doi: 10.1016/0002-9343(74)90167-3. [DOI] [PubMed] [Google Scholar]
  157. Sarlund H., Laakso M., Pyörälä K., Penttilä I. Association of serum lipids and lipoproteins with plasma C-peptide concentration in non-insulin-dependent diabetic and non-diabetic subjects. Metabolism. 1987 Sep;36(9):840–845. doi: 10.1016/0026-0495(87)90091-6. [DOI] [PubMed] [Google Scholar]
  158. Sarlund H., Laakso M., Voutilainen E., Penttilä I., Pyörälä K. Familial aggregation of non-insulin dependent diabetes and coronary heart disease are accompanied by different effects on serum lipids, lipoproteins and apolipoproteins. Atherosclerosis. 1991 Jan;86(1):17–29. doi: 10.1016/0021-9150(91)90095-k. [DOI] [PubMed] [Google Scholar]
  159. Schectman G., Kaul S., Kissebah A. H. Effect of fish oil concentrate on lipoprotein composition in NIDDM. Diabetes. 1988 Nov;37(11):1567–1573. doi: 10.2337/diab.37.11.1567. [DOI] [PubMed] [Google Scholar]
  160. Schneider W. J. The low density lipoprotein receptor. Biochim Biophys Acta. 1989 May 9;988(2):303–317. doi: 10.1016/0304-4157(89)90023-3. [DOI] [PubMed] [Google Scholar]
  161. Scott R. L., Kheshti A., Heimberg M., Wilcox H. G., Stone W. L. The role of selenium in the secretion of very-low-density lipoprotein in the isolated perfused rat liver. Biochem J. 1991 Nov 1;279(Pt 3):741–745. doi: 10.1042/bj2790741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. Seghieri G., Alviggi L., Caselli P., De Giorgio L. A., Breschi C., Gironi A., Niccolai M., Bartolomei G. C. Serum lipids and lipoproteins in type 2 diabetic patients with persistent microalbuminuria. Diabet Med. 1990 Nov;7(9):810–814. doi: 10.1111/j.1464-5491.1990.tb01497.x. [DOI] [PubMed] [Google Scholar]
  163. Shepherd J., Packard C. J., Grundy S. M., Yeshurun D., Gotto A. M., Jr, Taunton O. D. Effects of saturated and polyunsaturated fat diets on the chemical composition and metabolism of low density lipoproteins in man. J Lipid Res. 1980 Jan;21(1):91–99. [PubMed] [Google Scholar]
  164. Simons L. A., Hickie J. B., Balasubramaniam S. On the effects of dietary n-3 fatty acids (Maxepa) on plasma lipids and lipoproteins in patients with hyperlipidaemia. Atherosclerosis. 1985 Jan;54(1):75–88. doi: 10.1016/0021-9150(85)90155-8. [DOI] [PubMed] [Google Scholar]
  165. Sobey W. J., Beer S. F., Carrington C. A., Clark P. M., Frank B. H., Gray I. P., Luzio S. D., Owens D. R., Schneider A. E., Siddle K. Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins. Biochem J. 1989 Jun 1;260(2):535–541. doi: 10.1042/bj2600535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Stern M. P., Haffner S. M. Dyslipidemia in type II diabetes. Implications for therapeutic intervention. Diabetes Care. 1991 Dec;14(12):1144–1159. doi: 10.2337/diacare.14.12.1144. [DOI] [PubMed] [Google Scholar]
  167. Stout R. W. Insulin and atheroma--an update. Lancet. 1987 May 9;1(8541):1077–1079. doi: 10.1016/s0140-6736(87)90495-8. [DOI] [PubMed] [Google Scholar]
  168. Tall A., Sammett D., Granot E. Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia. J Clin Invest. 1986 Apr;77(4):1163–1172. doi: 10.1172/JCI112417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  169. Tam S. P. Effects of gemfibrozil and ketoconazole on human apolipoprotein AI, B and E levels in two hepatoma cell lines, HepG2 and Hep3B. Atherosclerosis. 1991 Nov;91(1-2):51–61. doi: 10.1016/0021-9150(91)90186-7. [DOI] [PubMed] [Google Scholar]
  170. Taskinen M. R., Kuusi T., Helve E., Nikkilä E. A., Yki-Järvinen H. Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes. Arteriosclerosis. 1988 Mar-Apr;8(2):168–177. doi: 10.1161/01.atv.8.2.168. [DOI] [PubMed] [Google Scholar]
  171. Temple R. C., Carrington C. A., Luzio S. D., Owens D. R., Schneider A. E., Sobey W. J., Hales C. N. Insulin deficiency in non-insulin-dependent diabetes. Lancet. 1989 Feb 11;1(8633):293–295. doi: 10.1016/s0140-6736(89)91306-8. [DOI] [PubMed] [Google Scholar]
  172. Thind I. S., Sandhu R. S. Signification of high density and total cholesterol and triglycerides in acute myocardial infarction -- a case-control study. Clin Biochem. 1981 Apr;14(2):57–60. doi: 10.1016/s0009-9120(81)90670-6. [DOI] [PubMed] [Google Scholar]
  173. Tikkanen M. J., Helve E., Jättelä A., Kaarsalo E., Lehtonen A., Malbecq W., Oksa H., Päkkönen P., Salmi J., Veharanta T. Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: the Finnish Multicenter Study. Am J Cardiol. 1988 Nov 11;62(15):35J–43J. doi: 10.1016/0002-9149(88)90005-7. [DOI] [PubMed] [Google Scholar]
  174. Uusitupa M., Siitonen O., Aro A., Pyörälä K. Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged, newly diagnosed type 2 (non-insulin-dependent) diabetic subjects. Diabetologia. 1985 Jan;28(1):22–27. doi: 10.1007/BF00276995. [DOI] [PubMed] [Google Scholar]
  175. Uusitupa M., Siitonen O., Pyörälä K., Aro A., Hersio K., Penttilä I., Voutilainen E. The relationship of cardiovascular risk factors to the prevalence of coronary heart disease in newly diagnosed type 2 (non-insulin-dependent) diabetes. Diabetologia. 1985 Sep;28(9):653–659. doi: 10.1007/BF00291970. [DOI] [PubMed] [Google Scholar]
  176. Van Lenten B. J., Fogelman A. M., Jackson R. L., Shapiro S., Haberland M. E., Edwards P. A. Receptor-mediated uptake of remnant lipoproteins by cholesterol-loaded human monocyte-macrophages. J Biol Chem. 1985 Jul 25;260(15):8783–8788. [PubMed] [Google Scholar]
  177. Wang S. R., Pessah M., Infante J., Catala D., Salvat C., Infante R. Lipid and lipoprotein metabolism in Hep G2 cells. Biochim Biophys Acta. 1988 Aug 12;961(3):351–363. doi: 10.1016/0005-2760(88)90082-3. [DOI] [PubMed] [Google Scholar]
  178. Weiland D., Mondon C. E., Reaven G. M. Evidence for multiple causality in the development of diabetic hypertriglyceridaemia. Diabetologia. 1980 Apr;18(4):335–340. doi: 10.1007/BF00251016. [DOI] [PubMed] [Google Scholar]
  179. Wieland H., Seidel D., Wiegand V., Kreuzer H. Serum lipoproteins and coronary artery disease (CAD). Comparison of the lipoprotein profile with the results of coronary angiography. Atherosclerosis. 1980 Jun;36(2):269–280. doi: 10.1016/0021-9150(80)90235-x. [DOI] [PubMed] [Google Scholar]
  180. Williams D. R., Byrne C., Clark P. M., Cox L., Day N. E., Rayman G., Wang T., Hales C. N. Raised proinsulin concentration as early indicator of beta cell dysfunction. BMJ. 1991 Jul 13;303(6794):95–96. doi: 10.1136/bmj.303.6794.95-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  181. Winocour P. H., Durrington P. N., Ishola M., Anderson D. C., Cohen H. Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin dependent diabetes mellitus. Br Med J (Clin Res Ed) 1987 Jun 27;294(6588):1648–1651. doi: 10.1136/bmj.294.6588.1648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Wong S., Nestel P. J. Eicosapentaenoic acid inhibits the secretion of triacylglycerol and of apoprotein B and the binding of LDL in Hep G2 cells. Atherosclerosis. 1987 Apr;64(2-3):139–146. doi: 10.1016/0021-9150(87)90239-5. [DOI] [PubMed] [Google Scholar]
  183. Wong S., Reardon M., Nestel P. Reduced triglyceride formation from long-chain polyenoic fatty acids in rat hepatocytes. Metabolism. 1985 Oct;34(10):900–905. doi: 10.1016/0026-0495(85)90135-0. [DOI] [PubMed] [Google Scholar]
  184. Xiang K. S., Cox N. J., Sanz N., Huang P., Karam J. H., Bell G. I. Insulin-receptor and apolipoprotein genes contribute to development of NIDDM in Chinese Americans. Diabetes. 1989 Jan;38(1):17–23. doi: 10.2337/diab.38.1.17. [DOI] [PubMed] [Google Scholar]
  185. Young I. R., Stout R. W. Effects of insulin and glucose on the cells of the arterial wall: interaction of insulin with dibutyryl cyclic AMP and low density lipoprotein in arterial cells. Diabete Metab. 1987 Jul;13(3 Pt 2):301–306. [PubMed] [Google Scholar]
  186. Yudkin J. S., Alberti K. G., McLarty D. G., Swai A. B. Impaired glucose tolerance. BMJ. 1990 Sep 1;301(6749):397–402. doi: 10.1136/bmj.301.6749.397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  187. Zampogna A., Luria M. H., Manubens S. J., Luria M. A. Relationship between lipids and occlusive coronary artery disease. Arch Intern Med. 1980 Aug;140(8):1067–1069. [PubMed] [Google Scholar]
  188. Zavaroni I., Bonora E., Pagliara M., Dall'Aglio E., Luchetti L., Buonanno G., Bonati P. A., Bergonzani M., Gnudi L., Passeri M. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med. 1989 Mar 16;320(11):702–706. doi: 10.1056/NEJM198903163201105. [DOI] [PubMed] [Google Scholar]
  189. Zavaroni I., Mazza S., Luchetti L., Buonanno G., Bonati P. A., Bergonzani M., Passeri M., Reaven G. M. High plasma insulin and triglyceride concentrations and blood pressure in offspring of people with impaired glucose tolerance. Diabet Med. 1990 Jul;7(6):494–498. doi: 10.1111/j.1464-5491.1990.tb01430.x. [DOI] [PubMed] [Google Scholar]
  190. Zilversmit D. B. Atherogenesis: a postprandial phenomenon. Circulation. 1979 Sep;60(3):473–485. doi: 10.1161/01.cir.60.3.473. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES